Harnessing the Body’s Natural Marijuana: Stony Brook’s New Drug for Pain and Cancer Treatment Gets FDA Clearance
The Stony Brook University scientists tied to the Institute of Chemical Biology and Drug Discovery (ICB & DD) discovered that Fatty Acid Binding Proteins (FABPs) are pharmacological targets of the body’s endocannabinoid system licensed to Artelo Biosciences, Inc. Fatty Acid Binding Proteins (FABPs) were identified as potential pharmacological targets for the treatment of cancer, inflammation,…


















































